Theravance Biopharma Inc

Small-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$17.03

+0.00 (+0.00%)

Analyst Consensus

Hold

Analysts

Moderate

Coverage

Buy 6 55%

Hold 5 45%

Sell 0 0%

Price Target

Analyst Price Target +46.5% upside

Low Target $16.23

Average Target $24.95

High Target $30.59

Current Price $17.03

Current
$17.03

Target
$24.95

$16.23 $24.95 avg $30.59

Scenario Analysis

Bear Case

$16.23

-4.7%

Low target

Base Case

$24.95

+46.5%

Avg target

Bull Case

$30.59

+79.6%

High target

Risk/Reward

17.0x

Highly favorable

Price in Context

52-Week High

$21.03

-19.0% from high

52-Week Low

$13.08

+30.2% from low

Target vs 52W High

$24.95

+18.6% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+15.6%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+11.3%
MRK Merck & Co. Inc.	Buy	36	72%	$159.27	+7.6%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+20.3%
BMY Bristol-Myers Squibb Co	Hold	35	43%	$174.50	+185.4%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-37.1%
ZTS Zoetis Inc	Hold	24	50%	$209.87	+193.1%